Skip to main content
Equibles

CONCORDBIO · Concord Biotech Limited

Use CONCORDBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CONCORDBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
594.00 INR -7.80 (-1.30%) At close · Nov 13
Rebalance outlook locked
Market Cap
124.28B INR
Shares
209.23M
Volume · Nov 13 154.64K Avg daily vol (8 sessions) 273.35K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close594.00 INR Open604.30 INR Day588.70–612.00 INR Since split594.00–672.70 INR Avg vol since split · 8d273K Last earningsOct 28, 2026 DataNov 2026–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Nov 4, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Nov 4, 2026.

Latest documents

2026
Oct 28
Earnings call
Q2 2027 earnings call

Concord Biotech Limited reported H1 FY27 revenue of 566.6 crores, up 26%, and PAT of 127.3 crores, up 19%, with EBITDA margin of 33%. Cash and cash equivalents were around 445 crores as of September 30, 2026.

All documents

Quarterly results

Revenue Net income Net loss
▲1.4% 2.44B INR 759.21M INR '25 Q3 ▲34.8% 4.30B INR 1.40B INR '25 Q4 ▼5.5% 2.04B INR 440.58M INR '26 Q1 ▼20.4% 2.47B INR 635.81M INR '26 Q2 ▲13.7% 2.78B INR 644.77M INR '26 Q3 ▼24.1% 3.26B INR 887.90M INR '26 Q4 ▲26.2% 2.57B INR 585.26M INR '27 Q1 LATEST ▲25.1% 3.09B INR 706.53M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its range since split · 2026-11-04
Range low 594.00 INR Now 594.00 INR · 0% Range high 672.70 INR

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Nov 4, 2026; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XNSE:CONCORDBIO -6.1% — — — —

Exchange listing

Market
XNSE
Ticker
CONCORDBIO
ISIN
INE338H01029
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.concordbiotech.com/
Investor relations
https://concordbiotech.com/investor/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-07-24 3.775 INR
2025-09-03 5.35 INR
2024-06-21 4.375 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-28 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-03 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-06-01 Transcript
    Earnings Call for the Quarter Ended March 31, 2026